StockGlow

Lakefront Biotherapeutics NV (GXEA.F)

Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe.

24.00+0.00%Healthcare
Compare GXEA.F with
StockGlow Score
12
Bearish
BearishBullish
1 year ago-15.5%

The outlook

Lakefront Biotherapeutics NV currently reads as bearish based on below its 50- & 200-day averages, 14% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range14% of the way from its 52-week low to high
Market cap
$1.57B
52-wk high
31.40
52-wk low
22.80
50-day avg
24.98
200-day avg
26.38
Trailing P/E
3.2

Similar stocks

GXE.FLakefront Biotherapeutics NV$24.06+0.84%DR6.FACADIA Pharmaceuticals Inc.$23.02+0.61%2L9.FVisionWave Holdings, Inc.$1.63-3.66%UP0.FUltragenyx Pharmaceutical Inc.$22.52+4.89%IM8N.SGInsmed Incorporated$89.09+1.82%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy